SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-008745
Filing Date
2024-03-20
Accepted
2024-03-20 16:29:31
Documents
1
Period of Report
2024-03-18

Document Format Files

Seq Description Document Type Size
1 form4-03202024_080321.html 4  
1 form4-03202024_080321.xml 4 9320
  Complete submission text file 0001415889-24-008745.txt   10857
Mailing Address C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address
GUGGENHIME ANDREW (Reporting) CIK: 0001230724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 24768150

Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)